Mazdutide
PRIME
Innovent · Phase 4 · Recruiting · Enrollment 60
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| GLP-1/GCG receptor dual agonist plus lifestyle optimization (GG Group) | Metabolic Dysfunction-Associated Steatohepati... | n/r | 1 | n/r | n/r |
| Lifestyle optimization only (LL group) | Metabolic Dysfunction-Associated Steatohepati... | n/r | 1 | n/r | n/r |